The regulation of miR-122 which is involved in Hepatitis C virus replication and interferon treatment response
The regulation of miR-122 which is involved in Hepatitis C virus replication and interferon treatment response
批准号:
23790774
负责人:
MUROYAMA Ryosuke
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mir-122 is a highly abundant and liver-specific miRNA, and reported to enhance Hepatitis C virus (HCV) replication and be associated with interferon treatment response and hepatocarcinogenesis. In this study, we investigated the regulation mechanism of miR-122. At first, we examined the correlation between the expression level of miR-122 and pri-miR-122 which was primary transcript of miR-122 in various hepatoma cell lines by realtime PCR. The result showed the positive correlation between miR-122 and pri-miR-122. Therefore, the expression level of pri-miR-122 was considered to be a major factor which determined that of miR-122. Next, we performed reporter gene assays integrated with truncation in the pri-miR-122 promoter, and determined the region which had high trans-activation effect. Next, we examined the DNA methylation status in the promoter region of pri-miR-122 by sodium bisulfite DNA sequencing, and found that the promoter region of pri-miR-122 was hyper-methylated in the hepatoma cell lines which have the low expression level of pri-miR-122. Moreover, with 5-aza-CdR treatment, the expression level of pri-miR-122 was increased in such cell lines. Therefore, the epigenetic regulation might play an important role in the expression of miR-122.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C 型肝炎の病態と治療効果を規定する miR122 の発現調節機構の解明。
阐明miR122的表达调控机制,决定丙型肝炎的病理和治疗效果。
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[室山良介, 後藤覚, Li Wenwen, 古渡礼恵, 加藤直也]
通讯作者:
加藤直也
C型肝炎の病態と治療効果を規定するmiR122の発現調節機構の解明
阐明决定丙型肝炎病理和治疗效果的miR122表达调控机制
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[室山良介, 後藤覚, Li Wenwen, 古渡礼恵, 加藤直也, 室山良介]
通讯作者:
室山良介
海外基金